Listen Now
Topics Covered
- Review of Chronic Lymphocytic Leukemia, in the Context of COVID-19
- Significant Role of Testing in Informing Your Treatment Choices
- First Line Treatment Options
- Treatment of Relapsed and Refractory CLL
- Re-Testing Importance in Determining Treatment for 2nd and 3rd Line Treatments
- Current Perspectives on New and Emerging Treatments of CLL
- Updates on Clinical Trials and Their Significance for CLL
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & Making Your List of Questions
- Practical Support to Cope with CLL
- Questions for Our Panel of Experts
Our Panel of Experts

Jennifer R. Brown, MD, PhD
Professor of Medicine, Harvard Medical School, Director, CLL Center, Dana Farber Cancer Institute

Mazyar Shadman, MD, MPH
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, Associate Professor, Medical Oncology Division, University of Washington, Attending Physician, Seattle Cancer Care Alliance

Patricia Koffman
Co-Founder & Communications Director CLL Society Inc.

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on April 08, 2021.